Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Anticoagulants in ischemia-guided management of non-ST-elevation acute coronary syndromes.

Mayer M.

Am J Emerg Med. 2017 Mar;35(3):502-507. doi: 10.1016/j.ajem.2016.12.070. Epub 2017 Jan 3. Review.

PMID:
28089498
2.
3.

Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trial.

Geisler T, Droppa M, Gawaz M, Steinhubl SR, Bertrand ME, Lincoff AM, Cequier AR, Desmet W, Rasmussen LH, Hoekstra JW, Bernstein D, Deliargyris EN, Mehran R, Stone GW.

Catheter Cardiovasc Interv. 2016 Aug;88(2):174-81. doi: 10.1002/ccd.26232. Epub 2015 Sep 2.

PMID:
26332193
4.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S; ESC Scientific Document Group .

Eur Heart J. 2016 Jan 14;37(3):267-315. doi: 10.1093/eurheartj/ehv320. Epub 2015 Aug 29. No abstract available.

5.

Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?

Huber K, Bates ER, Valgimigli M, Wallentin L, Kristensen SD, Anderson JL, Lopez Sendon JL, Tubaro M, Granger CB, Bode C, Ohman EM, Steg PG.

Am Heart J. 2014 Nov;168(5):611-21. doi: 10.1016/j.ahj.2014.06.014. Epub 2014 Jun 26. Review.

PMID:
25440788
6.

Clinical and economic studies of eptifibatide in coronary stenting.

Pasala T, Sattayaprasert P, Bhat PK, Athappan G, Gandhi S.

Ther Clin Risk Manag. 2014 Aug 2;10:603-14. doi: 10.2147/TCRM.S35664. eCollection 2014. Review. Erratum in: Ther Clin Risk Manag. 2014;10:913.

7.

Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non–ST Elevation Myocardial Infarction [Internet].

Melloni C, Jones WS, Washam JB, Hasselblad V, Mayer SB, Halim S, Subherwal S, Alexander K, Kong DF, Heidenfelder BL, Irvine RJ, Wing L, Dolor RJ.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov.

8.

A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial).

Collet JP, Huber K, Cohen M, Zeymer U, Goldstein P, Pollack C Jr, Silvain J, Henry P, Varenne O, Carrié D, Coste P, Angioi M, Le Breton H, Cayla G, Elhadad S, Teiger E, Filippi E, Aout M, Vicaut E, Montalescot G; ATOLL Investigators.

Am J Cardiol. 2013 Nov 1;112(9):1367-72. doi: 10.1016/j.amjcard.2013.07.003. Epub 2013 Sep 5.

PMID:
24012033
9.

Prognostic significance of bleeding location and severity among patients with acute coronary syndromes.

Vavalle JP, Clare R, Chiswell K, Rao SV, Petersen JL, Kleiman NS, Mahaffey KW, Wang TY.

JACC Cardiovasc Interv. 2013 Jul;6(7):709-17. doi: 10.1016/j.jcin.2013.03.010.

10.

Safety and efficacy of intense antithrombotic treatment and percutaneous coronary intervention deferral in patients with large intracoronary thrombus.

Echavarría-Pinto M, Lopes R, Gorgadze T, Gonzalo N, Hernández R, Jiménez-Quevedo P, Alfonso F, Bañuelos C, Nuñez-Gil IJ, Ibañez B, Fernández C, Fernandez-Ortiz A, García E, Macaya C, Escaned J.

Am J Cardiol. 2013 Jun 15;111(12):1745-50. doi: 10.1016/j.amjcard.2013.02.027. Epub 2013 Mar 22.

PMID:
23528026
11.

Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.

Leonardi S, Thomas L, Neely ML, Tricoci P, Lopes RD, White HD, Armstrong PW, Giugliano RP, Antman EM, Califf RM, Newby LK, Mahaffey KW.

J Am Coll Cardiol. 2012 Dec 4;60(22):2296-304. doi: 10.1016/j.jacc.2012.09.005. Epub 2012 Nov 1.

12.

Cost effectiveness of anticoagulation in acute coronary syndromes.

Latour-Pérez J, de-Miguel-Balsa E.

Pharmacoeconomics. 2012 Apr;30(4):303-21. doi: 10.2165/11589290-000000000-00000. Review.

PMID:
22409291
13.

The impact of postrandomization crossover of therapy in acute coronary syndromes care.

Mahaffey KW, Pieper KS, Lokhnygina Y, Califf RM, Antman EM, Kleiman NS, Goodman SG, White HD, Rao SV, Hochman JS, Cohen M, Col JJ, Roe MT, Ferguson JJ; SYNERGY Investigators.

Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):211-9. doi: 10.1161/CIRCOUTCOMES.109.853598. Epub 2011 Feb 8.

14.

Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial.

Zhang M, Tsiatis AA, Davidian M, Pieper KS, Mahaffey KW.

Biostatistics. 2011 Apr;12(2):258-69. doi: 10.1093/biostatistics/kxq054. Epub 2010 Aug 25.

15.
16.
17.

Fondaparinux: an overview.

Nadar SK, Goyal D, Shantsila E, Banerjee P, Lip GY.

Expert Rev Cardiovasc Ther. 2009 Jun;7(6):577-85. doi: 10.1586/erc.09.19.

PMID:
19505272
18.

Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease.

Chan MY, Mahaffey KW, Sun LJ, Pieper KS, White HD, Aylward PE, Ferguson JJ, Califf RM, Roe MT.

JACC Cardiovasc Interv. 2008 Aug;1(4):369-78. doi: 10.1016/j.jcin.2008.03.019. Erratum in: JACC Cardiovasc Interv. 2008 Oct;1(5):600-1.

19.

Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial).

Lansky AJ, Mehran R, Cristea E, Parise H, Feit F, Ohman EM, White HD, Alexander KP, Bertrand ME, Desmet W, Hamon M, Stone GW.

Am J Cardiol. 2009 May 1;103(9):1196-203. doi: 10.1016/j.amjcard.2009.01.030.

PMID:
19406258
20.

Cost-effectiveness analysis of anticoagulation strategies in non-ST-elevation acute coronary syndromes.

Maxwell CB, Holdford DA, Crouch MA, Patel DA.

Ann Pharmacother. 2009 Apr;43(4):586-95. doi: 10.1345/aph.1L498. Epub 2009 Mar 31.

PMID:
19336655

Supplemental Content

Loading ...
Support Center